Close Menu

No Place To Hide

When Pfizer bought Wyeth last year, the company said that it expected to cut about 15 percent of its workforce. However, on Friday, Pfizer said in a filing with the US Securities and Exchange Commission that the company will likely exceed that percentage, reports the Wall Street Journal. "At this point, it's too early to determine the extent to which we will exceed this target," says Joan Campion, a company spokesperson.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.